SOL Group reports first-half 2026 revenue growth and higher profit

SOL Group reported consolidated revenue of €948.6 million for the first half of 2026, up 8.5% from €874.1 million a year earlier, as approved by the Board of Directors of SOL S.p.A. The group posted a gross operating margin of €247.4 million, or 26.1% of revenue, and an operating result of €148.8 million, or 15.7% of revenue. Net profit reached €89.9 million, up 7.6% from €83.5 million. The group operates in technical and medical gases and home healthcare.

Key facts

Market context

Industrial gases such as oxygen, nitrogen, argon and carbon dioxide are produced by air separation and other processes, then supplied to customers as compressed gas, liquid or through pipelines. Technical gases serve steel, metal fabrication, chemicals, electronics, food and beverage, and general manufacturing, so demand tends to track industrial output. Medical gases, notably medical oxygen, support hospitals and clinics, while home healthcare services extend respiratory and oxygen therapy to patients at home, a segment that is generally less cyclical. Because gas producers rely on long-term supply contracts and fixed-cost networks of plants, cylinders and distribution, pricing discipline and utilisation rates strongly influence margins. Larger players with integrated networks can often absorb energy cost swings better than smaller suppliers, which shapes competition in regional markets.

Source: official release on solgroup.com. Summary and context written by Market Krystal.